Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medbright AI Investments Inc C.MBAI

Alternate Symbol(s):  MBAIF

MedBright AI Investments Inc. is a capital allocator focused on investing in healthcare technology companies. The Company is engaged in constructing a portfolio of synergistic investments to generate returns for shareholders. The Company is focused on significant near-term and midterm opportunities with potential returns while maintaining a commitment to governance. It is focused on investing in technology and artificial intelligence companies, combined with healthcare operators.


CSE:MBAI - Post by User

Post by MarketMakersson Jan 09, 2024 12:14pm
61 Views
Post# 35817538

Rejuvenation Medical Group as First International Customer

Rejuvenation Medical Group as First International Customer
Today, MBAI announced that Rejuvenation Medical Group, a prominent dermatology group and leader in advanced dermatological care, has decided to adopt MedMatrix across all its clinics in Canada, marking MBAI's First International Customer.
 
Rejuvenation Medical Group
Renowned for its cutting-edge dermatology treatments and facilities, Rejuvenation caters to over 750,000 patients each year with an extensive network including 9 clinics spread across 3 provinces.
 
The group boasts a highly skilled team comprising 21 dermatologists, 5 Mohs surgeons, 2 plastic surgeons and 13 general practitioners specializing in dermatology. Notably, Mohs surgery is a method for treating skin cancer lesions.
 
This strategic implementation of MedMatrix is set to enhance its already formidable healthcare offerings.
 
For over 40 years, Rejuvenation Medical Group has established a reputation for excellence in delivering world-class services and providing comprehensive medical, surgical, cosmetic and laser treatments.
 
MedMatrix
MedMatrix is an AI-powered data analytics platform that leverages artificial intelligence to analyze crucial aspects of healthcare facilities and work alongside healthcare professionals to drastically improve healthcare operations and enhance clinic revenue by 10% at no additional cost to the clinic.
 
Attesting to its strength as a platform, one of MBAI's beta customers is a Yale University School of Medicine affiliated clinic group.
 
Medical Director and Dermatologist at Rejuvenation, Paul Kuzel, MD, commented:
“In an operation as large and complex as ours, there is a clear need for AI to help improve the patient experience and clinic revenue,”
“We are excited to work with MedMatrix to improve our clinic operations across several areas in operations and research.”
 
Further, MBAI CEO Trevor Vieweg commented:
“Bringing Rejuvenation medical group and the entire team of highly talented medical professionals across their clinics as customers of the MedMatrix Platform is a major win for both sides,”
“The scale of Rejuvenation’s operations make it a perfect opportunity to show the value of MedMatrix. We look forward to demonstrating the benefits of MedMatrix in clinic operations at Rejuvenation.”
 
For more information on MBAI, refer to their corporate presentation: https://youtu.be/f3bcx2T_GzQ?si=wN0T3rYyaHdm45Ax
 
 
Posted on Behalf of MedBright AI Investments Inc.

<< Previous
Bullboard Posts
Next >>